Tele: 561.316.3330
Breaking Medical Device News

Monday, October 18, 2021

HomeCapillusCapillus Laser Therapy “Safe and Effective” at Treating Female Androgenetic Alopecia: Published...

Capillus Laser Therapy “Safe and Effective” at Treating Female Androgenetic Alopecia: Published Study


Capillus Laser Therapy Published Study to Treat Female Androgenetic Alopecia

A peer-reviewed study authored by Dr. Shelly Friedman, D.O., F.A.O.C.D. and supported by Patricia Schnoor, BSBA, confirms that low-level laser therapy (LLLT) with Capillus® may play a considerable role in the treatment of androgenetic alopecia for females, given the impartial evidence illustrating favorable hair regrowth results. The research was published in the June 2017 edition of Dermatologic Surgery, the official journal of the American Society for Dermatologic Surgery, encouraging familiarity of LLLT as a practical method of fighting hair loss at home within the greater medical community.

Dr. Friedman of the Scottsdale Institute for Cosmetic Dermatology is a board-certified hair restoration surgeon with nearly three decades of experience treating over 15,000 patients with hair loss. Patricia Schnoor is the head of quality assurance and governmental affairs at Capillus, overseeing the assembly, testing and quality control for Capillus’ line of FDA-cleared at-home laser caps.

The study’s circulation is expected to pave access to new international markets, allowing more individuals to undergo laser therapy hair loss treatment by way of physician prescription or recommendation.

Evidence Based Practice Guidelines:  Fernando Bermúdez, Director of International Distribution at Capillus, “Performing and publishing clinical research under the rigor of a prestigious journal is of critical importance for doctors prescribing under evidence based practice guidelines.” He added, “Published data is also a reference for increasingly savvy consumers wanting to make an educated purchase decision before committing to a long-term treatment.”

The purpose of this randomized controlled trial was to outline the effects of photobiomodulation, or laser light, on the hair follicle and surrounding tissues in patients suffering from hair loss. The subjects consisted of 44 healthy females ages 18 to 60 years who were recruited at two separate board–approved treatment sites.

The Capillus272™ Pro was used in the study under the alias of a “handi-dome” laser device. Using the discreet dome insert with laser diodes operating at 650 nm, active participants receiving LLLT with the Capillus272 Pro™ showed a 51 percent mean increase in hair counts compared to patients who used a seemingly identical yet defunct device.

The researchers concluded that low-level laser treatment administered for 30 minutes every other day for 17 weeks is both safe and effective in treating androgenetic alopecia in healthy females between the ages of 18 to 60 with Fitzpatrick skin Types I to IV and Ludwig–Savin Baldness Scale I-2 to II-2 baldness patterns. No side effects or adverse reactions were reported by any subject at any time during the study.

For more, view the published abstract on Dermatologic Surgery, June 2017 – Volume 43 – Edition 6.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Adam S. Epstein New CEO of AliMed, Inc.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth.

Tony Collins Appointed CFO of Xenter

“Xenter is building a platform for medical innovations that is transformational. The only way we can achieve our objectives is if we have great leaders like Tony Collins leading our company,” stated Richard J. Linder, Founder, Chairman & CEO of Xenter, Inc. “Tony brings incredible depth and experience to his new role as Chief Financial Officer.

Scott Sexton Appointed President at FIGUR8

"Scott brings to FIGUR8 30 years of workers' compensation, casualty, disability, and commercial health experience, most recently serving as a market leader for CorVel's national carrier practice sales team," said Nan-Wei Gong, CEO, and co-founder of FIGUR8.

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced...

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

By using this website you agree to accept Medical Device News Magazine Privacy Policy